{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T15:27:34Z","timestamp":1787326054978,"version":"build-2736575974"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Systemic lupus erythematosus (SLE) and diffuse large B-cell lymphoma (DLBCL) are both characterized by immune dysregulation. SLE has been reported as a risk factor for DLBCL. However, the common molecular and pathophysiological mechanisms of these two diseases are not fully understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We first used machine learning to screen for key immune-related genes (IRGs) that were common in SLE patients and DLBCL patients. These key IRGs may be key factors promoting the progression of DLBCL and were analyzed for their potential cross-talk mechanisms in the immune microenvironment of SLE and DLBCL. Finally, we verified the potential functions of IRGs in the development of DLBCL through cell experiments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A univariate analysis and machine learning confirmed that the CD247 molecule (CD247) was a common key gene in SLE and DLBCL. Meanwhile, the immune analysis results indicate that high expression of CD247 may enhance T-cell mediated anti-tumor immunity by regulating the immune infiltration of CD8 + T cells. Cell experiments have shown that overexpression of CD247 can significantly inhibit cell cycle progression and promote apoptosis in DLBCL cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>In short, this study determined that the CD247 gene may be a key gene in SLE-induced DLBCL, as it participates in the immune response and can induce DLBCL apoptosis and cell cycle changes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1707913","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T06:41:58Z","timestamp":1766040118000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["RETRACTED: Machine learning and validation reveal that immune-related genes in systemic lupus erythematosus regulate apoptosis and cycle progression in diffuse large B-cell lymphoma"],"prefix":"10.3389","volume":"12","author":[{"given":"Shengting","family":"Ruan","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Immunology, The Third Affiliated Hospital of Anhui Medical University","place":["Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, The Third Affiliated Hospital of Anhui Medical University","place":["Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, The Third Affiliated Hospital of Anhui Medical University","place":["Anhui, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"882891","DOI":"10.3389\/fmed.2022.882891","article-title":"Differences in the development of adverse infusion reactions to rituximab in patients with systemic lupus erythematosus, rheumatoid arthritis and non-Hodgkin's lymphoma-enigma variations","volume":"9","author":"Gilaberte Reyzabal","year":"2022","journal-title":"Front Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.semarthrit.2021.09.009","article-title":"Risk of malignancy in patients with systemic lupus erythematosus: systematic review and meta-analysis","volume":"51","author":"Clarke","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3390\/cancers15030835","article-title":"The immunology of DLBCL","volume":"15","author":"Takahara","year":"2023","journal-title":"Cancers"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e3558","DOI":"10.1002\/jgm.3558","article-title":"Identification of the shared gene signatures and molecular pathways in systemic lupus erythematosus and diffuse large B-cell lymphoma","volume":"25","author":"Li","year":"2023","journal-title":"J Gene Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"6310","DOI":"10.1038\/s41598-023-33585-2","article-title":"Bioinformatics analysis of the pathogenic link between Epstein-Barr virus infection, systemic lupus erythematosus and diffuse large B cell lymphoma","volume":"13","author":"Zhu","year":"2023","journal-title":"Sci Rep"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.47176\/mjiri.38.129","article-title":"Evaluation of genes and molecular pathways common between diffuse large B-cell lymphoma (DLBCL) and systemic lupus erythematosus (SLE): a systems biology approach","volume":"38","author":"Hejrati","year":"2024","journal-title":"Med J Islam Repub Iran"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.1038\/s41598-021-84568-0","article-title":"Reduced expression of innate immunity-related genes in lymph node metastases of luminal breast cancer patients","volume":"11","author":"Popeda","year":"2021","journal-title":"Sci Rep"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.2217\/fon-2022-0061","article-title":"The implications from the interplay of neoadjuvant chemoradiotherapy and the immune microenvironment in rectal cancer","volume":"18","author":"Shi","year":"2022","journal-title":"Future Oncol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s10528-024-10697-6","article-title":"Immunogenic cell death-related signature evaluates the tumor microenvironment and predicts the prognosis in diffuse large B-cell lymphoma","volume":"63","author":"Huang","year":"2025","journal-title":"Biochem Genet"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2425065","DOI":"10.1080\/07853890.2024.2425065","article-title":"SNRPB and CEP290, predicting the prognosis of diffuse large B cell lymphoma and associated with tumour immune microenvironment","volume":"56","author":"Tang","year":"2024","journal-title":"Ann Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1007\/s10495-024-01959-0","article-title":"DLD is a potential therapeutic target for COVID-19 infection in diffuse large B-cell lymphoma patients","volume":"29","author":"Chen","year":"2024","journal-title":"Apoptosis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"4995874","DOI":"10.1155\/2022\/4995874","article-title":"A novel immune-related gene signature predicts prognosis of lung adenocarcinoma","volume":"2022","author":"Ma","year":"2022","journal-title":"Biomed Res Int"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1007\/s10495-024-01996-9","article-title":"SNCA is a potential therapeutic target for COVID-19 infection in diffuse large B-cell lymphoma patients","volume":"29","author":"Chen","year":"2024","journal-title":"Apoptosis"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e24857","DOI":"10.1016\/j.heliyon.2024.e24857","article-title":"GPX4 is a potential diagnostic and therapeutic biomarker associated with diffuse large B lymphoma cell proliferation and B cell immune infiltration","volume":"10","author":"Chen","year":"2024","journal-title":"Heliyon"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12920-024-01853-3","article-title":"SLC27A2 is a potential immune biomarker for hematological tumors and significantly regulates the cell cycle progression of diffuse large B-cell lymphoma","volume":"17","author":"Wang","year":"2024","journal-title":"BMC Med Genet"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e19342","DOI":"10.1016\/j.heliyon.2023.e19342","article-title":"Prognostic and immunological characterization of diffuse large B-cell lymphoma evaluated by co-stimulatory molecular-related features","volume":"9","author":"Sheng","year":"2023","journal-title":"Heliyon."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s12672-025-01835-6","article-title":"Immunological characterization and prognostic of colon cancer evaluated by angiogenesis-related features: a computational analysis and in vitro experiments","volume":"16","author":"Liu","year":"2025","journal-title":"Discov Oncol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e70037","DOI":"10.1111\/jcmm.70037","article-title":"A comprehensive prognostic and immune infiltration analysis of UBA1 in pan-cancer: a computational analysis and in vitro experiments","volume":"28","author":"Chen","year":"2024","journal-title":"J Cell Mol Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s12672-025-01862-3","article-title":"Construction of regulatory T cells specific genes predictive models of prostate cancer patients based on machine learning: a computational analysis and in vitro experiments","volume":"16","author":"Zhou","year":"2025","journal-title":"Discov Oncol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/1074-7613(95)90140-X","article-title":"Identification and purification of human stat proteins activated in response to interleukin-2","volume":"2","author":"Hou","year":"1995","journal-title":"Immunity"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S1074-7613(00)80389-1","article-title":"An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor alpha chain induction","volume":"7","author":"Nakajima","year":"1997","journal-title":"Immunity"},{"key":"ref22","first-page":"5348","article-title":"Enforced expression of the Mr 33,000 Pim-1 kinase enhances factor-independent survival and inhibits apoptosis in murine myeloid cells","volume":"57","author":"Lilly","year":"1997","journal-title":"Cancer Res"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.leukres.2018.11.004","article-title":"Systemic lupus erythematosus and lymphoma: incidence, pathogenesis and biology","volume":"75","author":"Klein","year":"2018","journal-title":"Leuk Res"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev-pathmechdis-051222-115023","article-title":"Apoptosis in cancer biology and therapy","volume":"20","author":"Moyer","year":"2025","journal-title":"Annu Rev Pathol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s13238-021-00821-2","article-title":"Potentiating CD8+ T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling","volume":"12","author":"Yuan","year":"2021","journal-title":"Protein Cell"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41577-021-00571-6","article-title":"Neutrophils in cancer: heterogeneous and multifaceted","volume":"22","author":"Hedrick","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1158\/1078-0432.CCR-20-1319","article-title":"IL8, neutrophils, and NETs in a collusion against Cancer immunity and immunotherapy","volume":"27","author":"Teijeira","year":"2021","journal-title":"Clin Cancer Res"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nri.2017.52","article-title":"The non-canonical NF-\u03baB pathway in immunity and inflammation","volume":"17","author":"Sun","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1588486","DOI":"10.3389\/fimmu.2025.1588486","article-title":"The path less traveled: the non-canonical NF-\u03baB pathway in systemic lupus erythematosus","volume":"16","author":"Montano","year":"2025","journal-title":"Front Immunol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e2320421121","DOI":"10.1073\/pnas.2320421121","article-title":"TRAF3 loss-of-function reveals the noncanonical NF-\u03baB pathway as a therapeutic target in diffuse large B cell lymphoma","volume":"121","author":"Li","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1591615","DOI":"10.3389\/fimmu.2025.1591615","article-title":"Response gene to complement 32 promotes tumorigenesis by mediating DNA damage repair and inhibits CD8+ T cells infiltration in diffuse large B-cell lymphoma","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e18407","DOI":"10.1097\/MD.0000000000018407","article-title":"CD247 expression is associated with differentiation and classification in ovarian Cancer","volume":"98","author":"Ye","year":"2019","journal-title":"Medicine"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3390\/ijms23031328","article-title":"The apoptosis paradox in Cancer","volume":"23","author":"Morana","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1016\/j.scib.2025.03.054","article-title":"T cell-based cancer immunotherapy: opportunities and challenges","volume":"70","author":"Ma","year":"2025","journal-title":"Sci Bull"}],"updated-by":[{"DOI":"10.3389\/fmed.2026.1966628","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000}}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1707913\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T14:26:12Z","timestamp":1787322372000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1707913\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":34,"alternative-id":["10.3389\/fmed.2025.1707913"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1707913","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"article-number":"1707913"}}